Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1-6 of 6 for Atopic dermatitis (eczema)

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. A Study to Evaluate The Effectiveness and Safety of Abrocitinib, with or without Topical Medications, in Subjects Aged 12 Years and Older with Moderate-to-Severe Atopic Dermatitis

    Rochester, MN

  2. Bathing Additives in Pediatric Atopic Dermatitis

    Rochester, MN

  3. Study to Analyze the Metabolic Environment in Preventing Atopic Dermatitis

    Rochester, MN

  4. Excretion of Mast Cell Mediators in Children with Allergic Disorders

    Rochester, MN

  5. A Study of Patients Undergoing Therapy for Immune-Mediated Inflammatory Skin Conditions (IMISC)

    Rochester, MN

  6. A Study to Evaluate Bone Health and Contributing Factors in Children with Atopic Dermatitis

    Rochester, MN

.

Mayo Clinic Footer